Nutriband Inc. has signed a non-binding Letter of Intent with the Qvanta Group of Companies, a U.S.-based organization developing advanced quantum-AI cybersecurity and computing platforms. This partnership comes as President Trump designates illicit fentanyl as a Weapon of Mass Destruction, highlighting national security threats. Nutriband believes Qvanta’s capabilities can support its research and innovation efforts in developing abuse-deterrent pharmaceutical products. Under the LOI, potential collaboration areas include secure AI platforms for pharmaceutical data and cybersecurity frameworks. The partnership is subject to further review and agreement. Nutriband’s AVERSA™ technology aims to prevent abuse of drugs like fentanyl through transdermal patches.

Read more at GlobeNewswire: Nutriband Inc. Signs Letter of Intent with Qvanta Group of